#rcts search results

Ever wondered if #RCTs results are truly robust? 📊📈 Fragility index may be the solution! Find out more in the latest Statistical Spotlight from #EHJACVC 👇 bit.ly/3JT2YTc

ESC_Journals's tweet image. Ever wondered if #RCTs results are truly robust? 📊📈
Fragility index may be the solution!
Find out more in the latest Statistical Spotlight from #EHJACVC 👇
bit.ly/3JT2YTc

Are there differences in outcomes between limus vs paclitaxel #DCBs? 🤔 This meta-analysis of 6 #RCTs showed no difference in clinical outcomes! bit.ly/4cDlQm7 #JACCINT

JACCJournals's tweet image. Are there differences in outcomes between limus vs paclitaxel #DCBs? 🤔 

This meta-analysis of 6 #RCTs showed no difference in clinical outcomes! bit.ly/4cDlQm7 #JACCINT

We completed an IPDMA of #RCTs of #bivalirudin vs #heparin in #MI. Took >5 Ys!⏲️ #STEMI results in @JACCjournals. Consistent w BRIGH4, bival+high-dose post-PCI infusion ⬇️🩸⬇️ CVdeath @GreggWStone @crfheart: jacc.org/doi/10.1016/j.… Design: thieme-connect.com/products/ejour… @TH_Journal

bbikdeli's tweet image. We completed an IPDMA of #RCTs of #bivalirudin vs #heparin in #MI. Took >5 Ys!⏲️ #STEMI results in @JACCjournals. Consistent w BRIGH4, bival+high-dose post-PCI infusion ⬇️🩸⬇️ CVdeath @GreggWStone @crfheart:

jacc.org/doi/10.1016/j.…

Design: thieme-connect.com/products/ejour… @TH_Journal

Compelling evidence that if clinical trialists interested in the impact of treatment on health-related #qualityoflife include only generic measures and fail to include responsive and valid disease-specific measures in their #RCTs, they risk missing the crucial signal.


Lp(a) ⬆️the risk of ASCVD, but how about #VTE??🤔 🚨We summarize the existing pathophys & epidemiological data in @TH_Journal w an 👁️toward findings from #RCTs: thieme-connect.com/products/ejour… Great work #MarianaPfeferman🙏🙏 to 🌟team! #Cardiology #Lipids

bbikdeli's tweet image. Lp(a) ⬆️the risk of ASCVD, but how about #VTE??🤔

🚨We summarize the existing pathophys & epidemiological data in @TH_Journal w an 👁️toward findings from #RCTs: thieme-connect.com/products/ejour…  Great work #MarianaPfeferman🙏🙏 to 🌟team!  #Cardiology #Lipids

Check out the results from an individual-patient-data pooled analysis from 5 #RCTs investigating the Absorb bioresorbable vascular scaffold compared to #DES in 5,988 pts undergoing #PCI jacc.org/doi/10.1016/j.… #JACCINT #BVS @GreggWStone

JACCJournals's tweet image. Check out the results from an individual-patient-data pooled analysis from 5 #RCTs investigating the Absorb bioresorbable vascular scaffold compared to #DES in 5,988 pts undergoing #PCI jacc.org/doi/10.1016/j.…

#JACCINT #BVS @GreggWStone

In our SRMA of #RCTs #statins 💊 seemed safe in pts w #cancer. Key ❓is whether they also confer extra benefit ✅ for cardiovascular outcomes. #thrombosis Great working with @farbod_ZT @connors_md @BrighamResearch Link👇 buff.ly/3XmIomi

bbikdeli's tweet image. In our SRMA of #RCTs #statins 💊 seemed safe in pts w #cancer. Key ❓is whether they also confer extra benefit ✅ for cardiovascular outcomes. #thrombosis Great working with @farbod_ZT @connors_md  @BrighamResearch    Link👇

buff.ly/3XmIomi

How serious is the risk of myopathy and hepatotoxicity in patients with cancer receiving #statin 💊? Find out in our latest systematic review below 👇 Grateful for rockstar🌟 mentors @bbikdeli and @connors_md journals.sagepub.com/doi/10.1177/13…



#CompositeEndpoints in #RCTs: big problem. #BMJ survey of use in #cardiovascular trials: they make results look more important than they are through impression of benefits in death when only real effect in much less important outcomes (e.g. stent placement)


Just-published survey #simulation studies: how should #RCTs with binary outcomes address #MissingData? Multiple imputation best, single imputation, complete case less well. Data missing not at random, typical situation, nothing works well. Missing data risks #bias, too bad.


Authors of #RCTs who actually apply concealed #randomization and #blinding failed to report transparently in their articles. Making correct deductions requires inferences from clues in the study, contacting authors to get definitive information. pubmed.ncbi.nlm.nih.gov/15617948/


Discontinued randomized control trials (#RCTs) a problem. This #JAMA article presents the prevalence (almost 25%), characteristics (most frequently due to poor recruitment), & publication status (odds ratio>3 of not being published) of discontinued RCTs. pubmed.ncbi.nlm.nih.gov/24618966/


Advocates suggest administrative real-world data can substitute for #RCTs and offer propensity matching to reduce bias. But results often fail to correspond: #BMJ study showed direction of effect differed in 31% & CI failed to include #RCT estimate in 56% pubmed.ncbi.nlm.nih.gov/26858277/


RCTs don't often tell the whole story w their primary publication. In @JACCJournals @RosselloXavier @DLBHATTMD et al do a systematic survey of #extension reports of🫀#RCTs: jacc.org/doi/10.1016/j.… In the Editorial, we discuss the Dos & Don'ts👇: jacc.org/doi/10.1016/j.…

bbikdeli's tweet image. RCTs don't often tell the whole story w their primary publication. In @JACCJournals @RosselloXavier @DLBHATTMD  et al do a systematic survey of #extension reports of🫀#RCTs: jacc.org/doi/10.1016/j.…

In the Editorial, we discuss the Dos & Don'ts👇:
 jacc.org/doi/10.1016/j.…

Recent @cochranecollab Colombia Webinar: new #RiskofBias instrument for #RCTs, ROBUST-RCT @bmj_latest publication this year. Talk shows how ROBUST-RCT maintains rigor while achieving user-friendliness and simplicity. Prediction: ROBUST will become the go-to #instrument. #BMJ

GuyattGH's tweet card. Teleducación Facultad de Medicina UdeA

youtube.com

YouTube

Teleducación Facultad de Medicina UdeA


Live @SIRspecialists @SCAI Tune In next tuesday for a deep dive on all things re: Pulmonary Embolism. An expert panel will provide updates on completed and ongoing #RCTs for Endovascular Therapy. This is the place to get the latest expert perspectives. connect.sirweb.org/events/event-d…


🚀 when observation meets randomisation. Dive into the intersection of #RCTs and #RealWorld data in #HeartFailure & the challenges to innovate and adapt clinical trials doi.org/10.1002/ejhf.3… #HeartFailure #cardioX #EJHF @HFA_President @_antocannata @HanCardiomd @DjawidHashemi


Why is diversity at the ❤️ of today’s #ESCardioCRT discussion in Vienna? Clinical trialist Prof. Faiez Zannad explains why ESC experts and industry representatives are digging into the diversity issue for the future of #RCTs 👇 #RedesignRCTs #cardiotwitter


Explanatory or mechanistic #RCTs of physical or psychological interventions requires “#placebo,” or “#sham” comparators. This #BMJ article presents recommendations for designing, and reporting comparator interventions as well as a reporting checklist bmj.com/content/381/bm…


#ESCPatientForum member Richard Mindham shares four key actions to increase diversity in #RCTs: ✅Build capacity in India and Africa ✅Involve more patients in steering committees ✅Improve trust ✅Reduce inclusion criteria #ESCardioCRT #RedesignRCTs


Randomized trials in individual patients – N of 1 #RCTs - remain underutilized. This @AnnalsofIM paper describes our initial experience with 57 N of 1 RCTs. In 15, results prompted patients and clinicians to alter their treatment plans. pubmed.ncbi.nlm.nih.gov/2297206/


Why do some RCTs change stroke practice overnight while others don’t? Our new @StrokeAHA commentary examines the epistemology of #stroke #RCTs, and highlights the adoption (or not) of trial evidence through 4 clinical scenarios. doi.org/10.1161/STROKE…


#RCTs are essential for evaluating new treatments, yet ~20–25% are discontinued early (@JClinEpi). We surveyed researchers using EmbracePlus 👉92% achieved ≥75% completion. Better participant experience and onboarding can support sustained engagement. 🔗 bit.ly/48nHquO

empatica's tweet image. #RCTs are essential for evaluating new treatments, yet ~20–25% are discontinued early (@JClinEpi). We surveyed researchers using EmbracePlus 👉92% achieved ≥75% completion. Better participant experience and onboarding can support sustained engagement.
🔗 bit.ly/48nHquO
empatica's tweet image. #RCTs are essential for evaluating new treatments, yet ~20–25% are discontinued early (@JClinEpi). We surveyed researchers using EmbracePlus 👉92% achieved ≥75% completion. Better participant experience and onboarding can support sustained engagement.
🔗 bit.ly/48nHquO

The importance of #RCTs on the effects of exercise training in #cardiacrehab 🏃🏋🏻‍♀️ 👨‍🎓Prof. Rod Taylor kicks of the second day at the #ESCPrev26 in Linhart room.

TimKambic's tweet image. The importance of #RCTs on the effects of exercise training in #cardiacrehab 🏃🏋🏻‍♀️ 👨‍🎓Prof. Rod Taylor kicks of the second day at the #ESCPrev26 in Linhart room.

The #CardioHealth Alliance aims to improve care for patients w/ cardiovascular, renal, & metabolic diseases. @JavedButler1 & others share their expertise on multiorgan #RCTs for holistic treatments of these connected diseases in @JACCJournals 🔗doi.org/10.1016/j.jacc…

AllianceCardio's tweet image. The #CardioHealth Alliance aims to improve care for patients w/ cardiovascular, renal, & metabolic diseases. @JavedButler1 & others share their expertise on multiorgan #RCTs for holistic treatments of these connected diseases in @JACCJournals 🔗doi.org/10.1016/j.jacc…

The #CardioHealth Alliance aims to use real-world data to inform real-world care. Dr. Andrea Cherrington @UABHeersink highlights the importance of the Alliance’s work to expand access to #RCTs & bridge the gap between research findings & health care 🎥 youtu.be/F71YpqAu7B4

AllianceCardio's tweet card. Duke Clinical Research Institute

youtube.com

YouTube

Duke Clinical Research Institute


Does the #USFedGovt do #RCTs - clinical drug trials - too & w vast new data sets, #AIandMLwuAs? Yes: 1 gemini.google.com/share/18dce658… 2 share.google/aimode/ha7mXp5… How could @WorldUnivAndSch collaborate & w a #RealisticVirtualEarthForClinicalTrials & in all ~200 #WUaSMedSchs #WUaScountries?

DATA REPRODUCED: In old female mice, NMN restores ovarian follicle reserve in 10 days. Optimal dose was 200-500 mg/kg body weight/day. Equivalent to 35-45 in woman years. Clinical trials are needed 🐭🧓

davidasinclair's tweet image. DATA REPRODUCED: In old female mice, NMN restores ovarian follicle reserve in 10 days. Optimal dose was 200-500 mg/kg body weight/day. Equivalent to 35-45 in woman years. Clinical trials are needed 🐭🧓


Does the #USFedGovt do #RCTs - clinical drug trials - too & w vast new data sets, #AIandMLwuAs? Yes: 1 gemini.google.com/share/18dce658… 2 share.google/aimode/ha7mXp5… How could @WorldUnivAndSch collaborate & w a #RealisticVirtualEarthForClinicalTrials & in all ~200 #WUaSMedSchs #WUaScountries?


Does the #USFedGovt do #RCTs - clinical drug trials - too & w vast new data sets, #AIandMLwuAs? Yes: 1 gemini.google.com/share/18dce658… 2 share.google/aimode/ha7mXp5… How could @WorldUnivAndSch collaborate & w a #RealisticVirtualEarthForClinicalTrials & in all ~200 #WUaSMedSchs #WUaScountries?

DATA REPRODUCED: In old female mice, NMN restores ovarian follicle reserve in 10 days. Optimal dose was 200-500 mg/kg body weight/day. Equivalent to 35-45 in woman years. Clinical trials are needed 🐭🧓

davidasinclair's tweet image. DATA REPRODUCED: In old female mice, NMN restores ovarian follicle reserve in 10 days. Optimal dose was 200-500 mg/kg body weight/day. Equivalent to 35-45 in woman years. Clinical trials are needed 🐭🧓


Does the #USFedGovt do #RCTs - clinical drug trials - too & w vast new data sets, #AIandMLwuAs? Yes: 1 gemini.google.com/share/18dce658… 2 share.google/aimode/ha7mXp5… How could @WorldUnivAndSch collaborate & w a #RealisticVirtualEarthForClinicalTrials & in all ~200 #WUaSMedSchs #WUaScountries?

DATA REPRODUCED: In old female mice, NMN restores ovarian follicle reserve in 10 days. Optimal dose was 200-500 mg/kg body weight/day. Equivalent to 35-45 in woman years. Clinical trials are needed 🐭🧓

davidasinclair's tweet image. DATA REPRODUCED: In old female mice, NMN restores ovarian follicle reserve in 10 days. Optimal dose was 200-500 mg/kg body weight/day. Equivalent to 35-45 in woman years. Clinical trials are needed 🐭🧓


Does the #USFedGovt do #RCTs - clinical drug trials - too & w vast new data sets, #AIandMLwuAs? Yes: 1 gemini.google.com/share/18dce658… 2 share.google/aimode/ha7mXp5… How could @WorldUnivAndSch collaborate & w a #RealisticVirtualEarthForClinicalTrials & in all ~200 #WUaSMedSchs #WUaScountries?

DATA REPRODUCED: In old female mice, NMN restores ovarian follicle reserve in 10 days. Optimal dose was 200-500 mg/kg body weight/day. Equivalent to 35-45 in woman years. Clinical trials are needed 🐭🧓

davidasinclair's tweet image. DATA REPRODUCED: In old female mice, NMN restores ovarian follicle reserve in 10 days. Optimal dose was 200-500 mg/kg body weight/day. Equivalent to 35-45 in woman years. Clinical trials are needed 🐭🧓


Does the #USFedGovt do #RCTs - clinical drug trials - too, & w vast new data sets, AIandMLwuAs? Yes: 1 gemini.google.com/share/18dce658… 2 share.google/aimode/ha7mXp5… How could @WorldUnivAndSch collaborate & w a #RealisticVirtualEarthForClinicalTrials & in all ~200 #WUaSMedSch #WUaScountries?

DATA REPRODUCED: In old female mice, NMN restores ovarian follicle reserve in 10 days. Optimal dose was 200-500 mg/kg body weight/day. Equivalent to 35-45 in woman years. Clinical trials are needed 🐭🧓

davidasinclair's tweet image. DATA REPRODUCED: In old female mice, NMN restores ovarian follicle reserve in 10 days. Optimal dose was 200-500 mg/kg body weight/day. Equivalent to 35-45 in woman years. Clinical trials are needed 🐭🧓


Does the #USFedGovt do #RCTs - clinical drug trials - too, & w vast new data sets, AIandMLwuAs? Yes: 1 gemini.google.com/share/18dce658… 2 share.google/aimode/ha7mXp5… How could @WorldUnivAndSch collaborate & w a #RealisticVirtualEarthForClinicalTrials & in all ~200 #WUaSMedSch #WUaScountries?

DATA REPRODUCED: In old female mice, NMN restores ovarian follicle reserve in 10 days. Optimal dose was 200-500 mg/kg body weight/day. Equivalent to 35-45 in woman years. Clinical trials are needed 🐭🧓

davidasinclair's tweet image. DATA REPRODUCED: In old female mice, NMN restores ovarian follicle reserve in 10 days. Optimal dose was 200-500 mg/kg body weight/day. Equivalent to 35-45 in woman years. Clinical trials are needed 🐭🧓


Does the #USFedGovt do #RCTs - clinical drug trials - too, & w vast new data sets, AIandMLwuAs? Yes: 1 gemini.google.com/share/18dce658… 2 share.google/aimode/ha7mXp5… How could @WorldUnivAndSch collaborate & w a #RealisticVirtualEarthForClinicalTrials & in all ~200 #WUaSMedSch #WUaScountries?

DATA REPRODUCED: In old female mice, NMN restores ovarian follicle reserve in 10 days. Optimal dose was 200-500 mg/kg body weight/day. Equivalent to 35-45 in woman years. Clinical trials are needed 🐭🧓

davidasinclair's tweet image. DATA REPRODUCED: In old female mice, NMN restores ovarian follicle reserve in 10 days. Optimal dose was 200-500 mg/kg body weight/day. Equivalent to 35-45 in woman years. Clinical trials are needed 🐭🧓


Does the #USFedGovt do #RCTs - clinical drug trials - too, & w vast new data sets, AIandMLwuAs? Yes: 1 gemini.google.com/share/18dce658… 2 share.google/aimode/ha7mXp5… How could @WorldUnivAndSch collaborate & w a #RealisticVirtualEarthForClinicalTrials & in all ~200 #WUaSMedSch #WUaScountries?

DATA REPRODUCED: In old female mice, NMN restores ovarian follicle reserve in 10 days. Optimal dose was 200-500 mg/kg body weight/day. Equivalent to 35-45 in woman years. Clinical trials are needed 🐭🧓

davidasinclair's tweet image. DATA REPRODUCED: In old female mice, NMN restores ovarian follicle reserve in 10 days. Optimal dose was 200-500 mg/kg body weight/day. Equivalent to 35-45 in woman years. Clinical trials are needed 🐭🧓


Does the #USFedGovt do #RCTs - clinical drug trials - too, & w vast new data sets, AIandMLwuAs? Yes: 1 gemini.google.com/share/18dce658… 2 share.google/aimode/ha7mXp5… How could @WorldUnivAndSch collaborate & w a #RealisticVirtualEarthForClinicalTrials & in all ~200 #WUaSMedSch #WUaScountries?

DATA REPRODUCED: In old female mice, NMN restores ovarian follicle reserve in 10 days. Optimal dose was 200-500 mg/kg body weight/day. Equivalent to 35-45 in woman years. Clinical trials are needed 🐭🧓

davidasinclair's tweet image. DATA REPRODUCED: In old female mice, NMN restores ovarian follicle reserve in 10 days. Optimal dose was 200-500 mg/kg body weight/day. Equivalent to 35-45 in woman years. Clinical trials are needed 🐭🧓


This J-PAL policy insight synthesizes findings from eleven #RCTs demonstrating that informational “nudges” increase health insurance enrollment 📋 povertyactionlab.org/policy-insight…


Want to learn more about #RCTs? Check out our #ResearchResources on the elements of randomized evaluations for an intro to theory of change, measurement, study design, data analysis & more! povertyactionlab.org/resource/eleme…

JPAL_NA's tweet image. Want to learn more about #RCTs? Check out our #ResearchResources on the elements of randomized evaluations for an intro to theory of change, measurement, study design, data analysis & more! povertyactionlab.org/resource/eleme…

Results from well-designed #RCTs are important for informing policy making, regardless of the result. But null results can be difficult to act on. Learn more about how to think about designing & learning from studies with null results in this blog post: povertyactionlab.org/blog/11-8-24/n…


Let’s talk Housing First 🏠 Our @JPAL brief reviews the literature on several #RCTs to unpack the impact of Housing First programs on housing stability, criminal legal involvement, health, employment, & general findings on cost-effectiveness 💰 Read more: povertyactionlab.org/publication/po…

JPAL_NA's tweet image. Let’s talk Housing First 🏠 
Our @JPAL brief reviews the literature on several #RCTs to unpack the impact of Housing First programs on housing stability, criminal legal involvement, health, employment, & general findings on cost-effectiveness 💰
Read more: povertyactionlab.org/publication/po…

ERJ: #RCTs in #respiratory medicine require harmonisation. A core outcome set #COS is an agreed minimum set of outcomes that are critical for decision-making and should be evaluated in all future clinical trials. bit.ly/3XQmbtH

ERSpublications's tweet image. ERJ: #RCTs in #respiratory medicine require harmonisation. A core outcome set #COS is an agreed minimum set of outcomes that are critical for decision-making and should be evaluated in all future clinical trials. bit.ly/3XQmbtH

Ever wondered if #RCTs results are truly robust? 📊📈 Fragility index may be the solution! Find out more in the latest Statistical Spotlight from #EHJACVC 👇 bit.ly/3JT2YTc

ESC_Journals's tweet image. Ever wondered if #RCTs results are truly robust? 📊📈
Fragility index may be the solution!
Find out more in the latest Statistical Spotlight from #EHJACVC 👇
bit.ly/3JT2YTc

On-going #RCTs in conduction system pacing (#csp ) from @kvernooy #EHRA2023

netta_doc's tweet image. On-going #RCTs in conduction system pacing (#csp ) from @kvernooy

#EHRA2023

Spin and fragility in randomised controlled trials in the anaesthesia literature. Should results of RCTs be presented differently? New systematic review by Demarquette et al #statistics #RCTs #fragility bjanaesthesia.org/article/S0007-…

BJAJournals's tweet image. Spin and fragility in randomised controlled trials in the anaesthesia literature. Should results of RCTs be presented differently? New systematic review by Demarquette et al #statistics #RCTs #fragility

bjanaesthesia.org/article/S0007-…

This meta-analysis of #RCTs demonstrates that PRP may confer pain and function benefits in the setting of rotator cuff disease. #PRP #Shoulder #Meta-analysis ow.ly/oPcF50Mx9rH

ArthroscopyJ's tweet image. This meta-analysis of #RCTs demonstrates that PRP may confer pain and function benefits in the setting of rotator cuff disease.  #PRP #Shoulder #Meta-analysis

ow.ly/oPcF50Mx9rH

Are there differences in outcomes between limus vs paclitaxel #DCBs? 🤔 This meta-analysis of 6 #RCTs showed no difference in clinical outcomes! bit.ly/4cDlQm7 #JACCINT

JACCJournals's tweet image. Are there differences in outcomes between limus vs paclitaxel #DCBs? 🤔 

This meta-analysis of 6 #RCTs showed no difference in clinical outcomes! bit.ly/4cDlQm7 #JACCINT

With you @DrMarthaGulati for bringing change for representation of women in #Cardiology trials! Asked the question at @AHAScience #AHA23👇why do we allow <50% women recruited in #RCTs to be accepted? #savingwomenshearts #GoRed #29daysofRed

AnastasiaSMihai's tweet image. With you @DrMarthaGulati for bringing change for representation of women in #Cardiology trials!

Asked the question at @AHAScience #AHA23👇why do we allow &amp;lt;50% women recruited in #RCTs to be accepted?

#savingwomenshearts #GoRed #29daysofRed

FACTS! Women make up a small % of #cardiology trials We can change this by: ♥️enrolling into trials ♥️demanding federal funding ensures women are represented ♥️the biggest journals not publish trials that exclude 52% of the population. #savingwomenshearts #GoRed #29daysofRed



buff.ly/3LIiYIT Watchful waiting to surgery in men with mildly symptomatic or asymptomatic #InguinalHernia: an individual participant data meta-analysis of long-term follow-up of #RCTs. #HerniaSurgery #GroinHernia

eurohernias's tweet image. buff.ly/3LIiYIT Watchful waiting to surgery in men with mildly symptomatic or asymptomatic #InguinalHernia: an individual participant data meta-analysis of long-term follow-up of #RCTs. 

#HerniaSurgery #GroinHernia
eurohernias's tweet image. buff.ly/3LIiYIT Watchful waiting to surgery in men with mildly symptomatic or asymptomatic #InguinalHernia: an individual participant data meta-analysis of long-term follow-up of #RCTs. 

#HerniaSurgery #GroinHernia
eurohernias's tweet image. buff.ly/3LIiYIT Watchful waiting to surgery in men with mildly symptomatic or asymptomatic #InguinalHernia: an individual participant data meta-analysis of long-term follow-up of #RCTs. 

#HerniaSurgery #GroinHernia
eurohernias's tweet image. buff.ly/3LIiYIT Watchful waiting to surgery in men with mildly symptomatic or asymptomatic #InguinalHernia: an individual participant data meta-analysis of long-term follow-up of #RCTs. 

#HerniaSurgery #GroinHernia

A collection of #ResearchResources from @JPAL_NA provides guidance for researchers conducting #RCTs in health care. Topics include: 📑Publishing in a medical journal 🏥Navigating hospital IRBs 🔢Power calculations for health-related studies j-p.al/p11

JPAL_NA's tweet image. A collection of #ResearchResources from @JPAL_NA provides guidance for researchers conducting #RCTs in health care. Topics include: 
📑Publishing in a medical journal
🏥Navigating hospital IRBs
🔢Power calculations for health-related studies
j-p.al/p11

We completed an IPDMA of #RCTs of #bivalirudin vs #heparin in #MI. Took >5 Ys!⏲️ #STEMI results in @JACCjournals. Consistent w BRIGH4, bival+high-dose post-PCI infusion ⬇️🩸⬇️ CVdeath @GreggWStone @crfheart: jacc.org/doi/10.1016/j.… Design: thieme-connect.com/products/ejour… @TH_Journal

bbikdeli's tweet image. We completed an IPDMA of #RCTs of #bivalirudin vs #heparin in #MI. Took &amp;gt;5 Ys!⏲️ #STEMI results in @JACCjournals. Consistent w BRIGH4, bival+high-dose post-PCI infusion ⬇️🩸⬇️ CVdeath @GreggWStone @crfheart:

jacc.org/doi/10.1016/j.…

Design: thieme-connect.com/products/ejour… @TH_Journal

In our SRMA of #RCTs #statins 💊 seemed safe in pts w #cancer. Key ❓is whether they also confer extra benefit ✅ for cardiovascular outcomes. #thrombosis Great working with @farbod_ZT @connors_md @BrighamResearch Link👇 buff.ly/3XmIomi

bbikdeli's tweet image. In our SRMA of #RCTs #statins 💊 seemed safe in pts w #cancer. Key ❓is whether they also confer extra benefit ✅ for cardiovascular outcomes. #thrombosis Great working with @farbod_ZT @connors_md  @BrighamResearch    Link👇

buff.ly/3XmIomi

How serious is the risk of myopathy and hepatotoxicity in patients with cancer receiving #statin 💊? Find out in our latest systematic review below 👇 Grateful for rockstar🌟 mentors @bbikdeli and @connors_md journals.sagepub.com/doi/10.1177/13…



Lp(a) ⬆️the risk of ASCVD, but how about #VTE??🤔 🚨We summarize the existing pathophys & epidemiological data in @TH_Journal w an 👁️toward findings from #RCTs: thieme-connect.com/products/ejour… Great work #MarianaPfeferman🙏🙏 to 🌟team! #Cardiology #Lipids

bbikdeli's tweet image. Lp(a) ⬆️the risk of ASCVD, but how about #VTE??🤔

🚨We summarize the existing pathophys &amp;amp; epidemiological data in @TH_Journal w an 👁️toward findings from #RCTs: thieme-connect.com/products/ejour…  Great work #MarianaPfeferman🙏🙏 to 🌟team!  #Cardiology #Lipids

bit.ly/4fdCdr9 Prophylactic mesh reinforcement versus primary suture for abdominal wall closure after elective #AAA repair with midline laparotomy incision: Updated systematic review including time-to-event meta-analysis and trial sequential analysis of #RCTs.

eurohernias's tweet image. bit.ly/4fdCdr9 Prophylactic mesh reinforcement versus primary suture for abdominal wall closure after elective #AAA repair with midline laparotomy incision: Updated systematic review including time-to-event meta-analysis and trial sequential analysis of #RCTs.
eurohernias's tweet image. bit.ly/4fdCdr9 Prophylactic mesh reinforcement versus primary suture for abdominal wall closure after elective #AAA repair with midline laparotomy incision: Updated systematic review including time-to-event meta-analysis and trial sequential analysis of #RCTs.
eurohernias's tweet image. bit.ly/4fdCdr9 Prophylactic mesh reinforcement versus primary suture for abdominal wall closure after elective #AAA repair with midline laparotomy incision: Updated systematic review including time-to-event meta-analysis and trial sequential analysis of #RCTs.
eurohernias's tweet image. bit.ly/4fdCdr9 Prophylactic mesh reinforcement versus primary suture for abdominal wall closure after elective #AAA repair with midline laparotomy incision: Updated systematic review including time-to-event meta-analysis and trial sequential analysis of #RCTs.

Will this ADHD medication help my patient? Bridging the gap between efficacy & effectiveness buff.ly/4h4Df8Y Is it time to reconsider the value we place on RCTs when they do not include the vast majority of people who need help? #ADHD #Medication #RCTs

Mental_Elf's tweet image. Will this ADHD medication help my patient? Bridging the gap between efficacy &amp;amp; effectiveness buff.ly/4h4Df8Y 

Is it time to reconsider the value we place on RCTs when they do not include the vast majority of people who need help?

#ADHD #Medication #RCTs

On #WomensHealthResearchDay a reminder for everyone👇stated similar introducing my @AHAScience #AHA23 presentation👉 "we have 50% as cut off for pass for exams but allow #RCTs to include <50% #women😞 #TimeForChange

AnastasiaSMihai's tweet image. On #WomensHealthResearchDay a reminder for everyone👇stated similar introducing my @AHAScience #AHA23 presentation👉
&quot;we have 50% as cut off for pass for exams but allow #RCTs to include &amp;lt;50% #women😞 

#TimeForChange

Women represent 51% of the nation’s population. Women are not a niche market. On #WomensHealthResearchDay, SWHR once again celebrates the White House Initiative on Women’s Health Research and looks forward to advances in the federal research landscape: ow.ly/8KVW50Qu4yB

SWHR's tweet image. Women represent 51% of the nation’s population. Women are not a niche market. On #WomensHealthResearchDay, SWHR once again celebrates the White House Initiative on Women’s Health Research and looks forward to advances in the  federal research landscape: ow.ly/8KVW50Qu4yB


How do you match tMCS to hemodynamics in #cardiogenicshock? @ebohula shares key insights & lessons from #RCTs@ddbergMD⁩ ⁦@ankeetbhatt⁩ ⁦@jameshorowitzmd⁩ ⁦@carlosalviar⁩ ⁦@JasonKatzMD⁩ ⁦@BalimSenmanMD⁩ ⁦@manreetkanwar#critcarecards23

ShashankSinhaMD's tweet image. How do you match tMCS to hemodynamics in #cardiogenicshock? @ebohula shares key insights &amp;amp; lessons from #RCTs ⁦@ddbergMD⁩ ⁦@ankeetbhatt⁩ ⁦@jameshorowitzmd⁩ ⁦@carlosalviar⁩ ⁦@JasonKatzMD⁩ ⁦@BalimSenmanMD⁩ ⁦@manreetkanwar⁩ #critcarecards23
ShashankSinhaMD's tweet image. How do you match tMCS to hemodynamics in #cardiogenicshock? @ebohula shares key insights &amp;amp; lessons from #RCTs ⁦@ddbergMD⁩ ⁦@ankeetbhatt⁩ ⁦@jameshorowitzmd⁩ ⁦@carlosalviar⁩ ⁦@JasonKatzMD⁩ ⁦@BalimSenmanMD⁩ ⁦@manreetkanwar⁩ #critcarecards23
ShashankSinhaMD's tweet image. How do you match tMCS to hemodynamics in #cardiogenicshock? @ebohula shares key insights &amp;amp; lessons from #RCTs ⁦@ddbergMD⁩ ⁦@ankeetbhatt⁩ ⁦@jameshorowitzmd⁩ ⁦@carlosalviar⁩ ⁦@JasonKatzMD⁩ ⁦@BalimSenmanMD⁩ ⁦@manreetkanwar⁩ #critcarecards23
ShashankSinhaMD's tweet image. How do you match tMCS to hemodynamics in #cardiogenicshock? @ebohula shares key insights &amp;amp; lessons from #RCTs ⁦@ddbergMD⁩ ⁦@ankeetbhatt⁩ ⁦@jameshorowitzmd⁩ ⁦@carlosalviar⁩ ⁦@JasonKatzMD⁩ ⁦@BalimSenmanMD⁩ ⁦@manreetkanwar⁩ #critcarecards23

We can’t enroll in #SLE #RCTs Fixes #Pragmatic active A vs B ?emulation studies Adaptive design Shorten trial duration to 6/12 in nonrenal RCTs Withdrawal of #prednisone Flare prevention RCTs Not addressing actual pts ⁦@RheumNow#LUPUS2025

Janetbirdope's tweet image. We can’t enroll in #SLE #RCTs 
Fixes
#Pragmatic active A vs B 

?emulation studies 
Adaptive design 
Shorten trial duration to 6/12 in nonrenal RCTs 
Withdrawal of #prednisone 
Flare prevention 

RCTs Not addressing actual pts 

⁦@RheumNow⁩ #LUPUS2025

Combination advanced #therapies in #IBD Need the #RCTs but it is the way forward for some Pts #Mentoring in #IBD XXV ⁦@ScopeCanMD

Janetbirdope's tweet image. Combination advanced #therapies in #IBD

Need the #RCTs but it is the way forward for some Pts 

#Mentoring in #IBD XXV

⁦@ScopeCanMD⁩

Check out the results from an individual-patient-data pooled analysis from 5 #RCTs investigating the Absorb bioresorbable vascular scaffold compared to #DES in 5,988 pts undergoing #PCI jacc.org/doi/10.1016/j.… #JACCINT #BVS @GreggWStone

JACCJournals's tweet image. Check out the results from an individual-patient-data pooled analysis from 5 #RCTs investigating the Absorb bioresorbable vascular scaffold compared to #DES in 5,988 pts undergoing #PCI jacc.org/doi/10.1016/j.…

#JACCINT #BVS @GreggWStone

Loading...

Something went wrong.


Something went wrong.